Geoffrey Gotto

1.5k citations
59 papers · 882 indexed · 1 hit paper · h-index 14

Geoffrey Gotto

56 papers receiving 871 citations

Hit Papers

Improved Outcomes with Enzalutamide in Biochemically Recu...1142023202620242025255075100

Peers

Geoffrey Gotto
Comparison fields: 5 of 87
  • Endocrinology 103
  • Urology 125
  • Pulmonary and Respiratory Medicine 515
  • Rheumatology 136
  • Food Science 97
Replace H Bauer with:
H Bauer Germany
Marco Grasso Italy
Atsuko Iwata Japan
K. H. Kurth Netherlands
Irving M. Bush United States
Uzma Shah United States
A Masi Italy
Ulrike Zwergel Germany
Anna Kołodziej Poland
Christoph Bobrowski Germany
Geoffrey Gotto relative to H Bauer Germany H Bauer's profile →
Citations per field
00.5×12.1×
H Bauer · 1×
Citations per year

Countries citing papers authored by Geoffrey Gotto

Since Specialization
Citations

This map shows the geographic impact of Geoffrey Gotto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffrey Gotto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffrey Gotto more than expected).

Fields of papers citing papers by Geoffrey Gotto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geoffrey Gotto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffrey Gotto. The network helps show where Geoffrey Gotto may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Geoffrey Gotto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Geoffrey Gotto Line = papers co-authored together Geoffrey Gotto links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20251
3 20232
4 20234
5 20231
6 20232
7 20231
8 20225
9 20222
10 202210
11 20218
12 20194
13 201910
14 20183
15 201716
16 201415
17 20138
18 20133
19 20118
20 201010

About Geoffrey Gotto

Geoffrey Gotto is a scholar working on Urology, Pulmonary and Respiratory Medicine and Oncology, having authored 59 papers that have together received 882 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (33 papers), Prostate Cancer Diagnosis and Treatment (16 papers), Radiopharmaceutical Chemistry and Applications (11 papers), Bladder and Urothelial Cancer Treatments (10 papers), Urological Disorders and Treatments (7 papers), Cancer, Lipids, and Metabolism (6 papers), Urinary and Genital Oncology Studies (6 papers) and Hormonal and reproductive studies (5 papers). The work is most often cited by research in Endocrinology (103 citations), Urology (125 citations) and Pulmonary and Respiratory Medicine (515 citations). Geoffrey Gotto has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include James A. Eastham, Farhang Rabbani, Peter T. Scardino, B. Brett Finlay, John H. Brumell, Carrie M. Rosenberger, Sandra L. Marcus, Luis Herran Yunis, Kiril Trpkov and Kinjal Vora. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026